Attached files
| file | filename |
|---|---|
| EX-1.1 - EX-1.1 - Durata Therapeutics, Inc. | d511012dex11.htm |
| S-1/A - S-1/A - Durata Therapeutics, Inc. | d511012ds1a.htm |
| EX-5.1 - EX-5.1 - Durata Therapeutics, Inc. | d511012dex51.htm |
Exhibit 23.1
CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
Durata Therapeutics, Inc:
We consent to the use of our report dated March 8, 2013, included herein, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
April 9, 2013